GOPAL AGARWAL

Takeda Emphasizes the Need for Cross-sectoral Alliances to Address the Burden of Vector-Borne Infectious Diseases

New Delhi [India], Takeda Biopharmaceuticals India Pvt. Ltd. (formerly Baxalta Bioscience India Private Limited) - a global values-based, R&D-driven biopharmaceutical leader - presented an industry perspective on the substantial need for vaccine equity and novel strategies for vector-borne disease financing at the Asian Venture Philanthropy Network (AVPN) South Asia Summit December 2023 (avpn.asia/event/avpn-south-asia-summit-december-2023/).